UBE Yönetim

Yönetim kriter kontrolleri 0/4

UBE CEO'su Masato Izumihara, Apr2019 tarihinde atandı, in görev süresi 5.58 yıldır. şirketin hisselerinin 0.058% doğrudan sahiptir ve bu hisselerin değeri ¥ 138.67M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.6 yıl ve 2.4 yıldır.

Anahtar bilgiler

Masato Izumihara

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	5.6yrs
CEO sahipliği	0.06%
Yönetim ortalama görev süresi	1.6yrs
Yönetim Kurulu ortalama görev süresi	2.4yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Masato Izumihara'un ücretlendirmesi UBE'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	JP¥20b
Jun 30 2024	n/a	n/a	JP¥30b
Mar 31 2024	n/a	n/a	JP¥29b
Dec 31 2023	n/a	n/a	JP¥14b
Sep 30 2023	n/a	n/a	JP¥2b
Jun 30 2023	n/a	n/a	-JP¥9b
Mar 31 2023	JP¥116m	JP¥43m	-JP¥7b

Tazminat ve Piyasa: Masato şirketinin toplam tazminatının JP pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.

Tazminat ve Kazançlar: Masato şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.

CEO

Masato Izumihara (63 yo)

5.6yrs

Görev süresi

JP¥116,100,000

Tazminat

Mr. Masato Izumihara has been President and Chief Executive Officer at Ube Industries, Ltd. since April 1, 2019 and serves as its Company President of Chemicals Company. Mr. Izumihara served as Senior Mana...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Masato Izumihara	President	5.6yrs	JP¥116.10m	0.058% ¥ 138.7m
Hirotaka Ishikawa	Executive Officer	1.6yrs	Veri yok	0.0033% ¥ 7.9m
Shinsuke Tokumitsu	General Manager of Investor & Public Relations Department	no data	Veri yok	Veri yok
Yuki Nishida	Sr. Managing EO	less than a year	Veri yok	Veri yok
Hisaaki Yokoo	Managing Executive Officer & GM of Elastomer Div.	5.6yrs	Veri yok	Veri yok
Keiichi Nagata	Sr. Managing Executive Officer & General Manager	5.6yrs	Veri yok	Veri yok
Yoichi Funayama	Managing Executive Officer & GM of Pharmaceutical Div.	2.6yrs	Veri yok	Veri yok
Ryo Kawamura	CRO, CCO & Executive Officer	less than a year	Veri yok	Veri yok
Futoshi Takase	Managing Executive Officer & General Manager of Ube Works	1.6yrs	Veri yok	Veri yok
Masayoshi Ota	Managing Executive Officer & President of UBE CORPORATION AMERICA INC.	less than a year	Veri yok	Veri yok
Watchara Pattananijnirundorn	Senior Exe. Off. and President & CEO of UBE Chemicals (Asia) Public Company Ltd.	no data	Veri yok	Veri yok
José Ignacio Iglesias	President of UBE CORPORATION EUROPE S.A.U. & Executive Officer	less than a year	Veri yok	Veri yok

1.6yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 4208 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.6 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Masato Izumihara	President	6.4yrs	JP¥116.10m	0.058% ¥ 138.7m
Hirotaka Ishikawa	Executive Officer	1.4yrs	Veri yok	0.0033% ¥ 7.9m
Yuki Nishida	Sr. Managing EO	no data	Veri yok	Veri yok
Yuzuru Yamamoto	Chairman of the Board	11.4yrs	Veri yok	0.073% ¥ 174.7m
Tatsuya Tanaka	Independent Outside Director	1.4yrs	Veri yok	0.00041% ¥ 975.4k
Tsugio Mitsuoka	Independent Outside Director	1.4yrs	Veri yok	0.00031% ¥ 737.5k
Masayuki Fujii	Director	5.8yrs	Veri yok	0.025% ¥ 59.0m
Satoko Suzuki	Independent Outside Director	2.4yrs	Veri yok	Veri yok
Takefumi Fukumizu	Independent Outside Director	2.4yrs	Veri yok	0.0019% ¥ 4.4m
Tamesaburo Yamamoto	Independent Outside Director	2.4yrs	Veri yok	Veri yok

2.4yrs

Ortalama Görev Süresi

66yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 4208 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.4 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

UBE Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

UBE Corporation, Annual General Meeting, Jun 26, 2024

UBE Corporation Announces Appointment of Hideo Tamada as Director, Effective April 1, 2024

UBE Corporation Announces Organizational and Personnel Changes

Less than half of directors are independent

UBE Corporation Announces Resignation of Tetsuro Higashi, Outside Director, Effective January 4, 2023

Less than half of directors are independent

Recent updates

New major risk - Financial position

Second quarter 2025 earnings released: JP¥46.20 loss per share (vs JP¥55.26 profit in 2Q 2024)

Getting In Cheap On UBE Corporation (TSE:4208) Might Be Difficult

UBE Corporation Revises Earnings Forecast for the First Half of Fiscal Year Ending March 31, 2025

Investors Could Be Concerned With UBE's (TSE:4208) Returns On Capital

iSigma Capital Corporation agreed to acquire 84.25% stake in Ube Steel Co.,Ltd from UBE Corporation (TSE:4208).

Upcoming dividend of JP¥55.00 per share

First quarter 2025 earnings released: EPS: JP¥49.49 (vs JP¥37.67 in 1Q 2024)

Investor sentiment deteriorates as stock falls 19%

Final dividend of JP¥55.00 announced

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased by 9.8% to JP¥3,092

Consensus EPS estimates increase by 14%

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

UBE Corporation to Report First Half, 2025 Results on Nov 07, 2024

Now 21% overvalued after recent price rise

Is UBE (TSE:4208) A Risky Investment?

UBE Corporation, Annual General Meeting, Jun 26, 2024

Estimating The Fair Value Of UBE Corporation (TSE:4208)

Price target increased by 8.3% to JP¥2,817

Upcoming dividend of JP¥50.00 per share

Market Participants Recognise UBE Corporation's (TSE:4208) Earnings

UBE Corporation to Report Fiscal Year 2024 Results on May 13, 2024

UBE Corporation Announces Appointment of Hideo Tamada as Director, Effective April 1, 2024

Third quarter 2024 earnings released: EPS: JP¥113 (vs JP¥8.39 loss in 3Q 2023)

Second quarter 2024 earnings released: EPS: JP¥55.26 (vs JP¥62.67 loss in 2Q 2023)

Upcoming dividend of JP¥50.00 per share at 3.7% yield

Now 21% undervalued

First quarter 2024 earnings released: EPS: JP¥37.67 (vs JP¥59.25 in 1Q 2023)

Price target increased by 13% to JP¥2,537

UBE Corporation Announces Dividend for the Year Ended March 31, 2023

Full year 2023 earnings released: JP¥72.25 loss per share (vs JP¥249 profit in FY 2022)

Consensus EPS estimates fall by 27%

Upcoming dividend of JP¥45.00 per share at 4.7% yield

Consensus EPS estimates fall by 15%

Consensus EPS estimates fall by 161%

Price target decreased by 7.3% to JP¥2,103

UBE Corporation Announces Organizational and Personnel Changes

Third quarter 2023 earnings released: JP¥8.39 loss per share (vs JP¥88.13 profit in 3Q 2022)

UBE Corporation to Report Q4, 2023 Results on May 12, 2023

Price target decreased to JP¥2,187

Less than half of directors are independent

Consensus forecasts updated

UBE Corporation Announces Resignation of Tetsuro Higashi, Outside Director, Effective January 4, 2023

Now 20% undervalued after recent price drop

Consensus EPS estimates fall by 51%

Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)

Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)

UBE Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

UBE Corporation Revises Earnings Guidance for the First Half Ended September 30, 2022 and Full Year Ending March 31, 2023

Santen Inc. and UBE Corporation Receives FDA Approval for OMLONTI(R) (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Upcoming dividend of JP¥50.00 per share

Consensus forecasts updated

UBE Corporation Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥59.25 (vs JP¥47.31 in 1Q 2022)

UBE Corp American Depositary Receipts - Unsponsored to Be Deleted from Other OTC

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Consensus forecasts updated

Ube Corporation Provides Consolidated Earnings Guidance for the Period Ending September 2022 and March 31, 2023

Less than half of directors are independent

UBE Corporation to Report Q2, 2023 Results on Nov 04, 2022

UBE Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Ube Industries, Ltd. Announces Appointment of Makoto Koyama as Director, Effective April 1, 2022

Ube Industries, Ltd. Announces Abolishment of Construction Materials Company and Machinery Company and Eliminates Osaka Branch

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ube Industries, Ltd. Announces Dividend for Second Quarter Ended April 2021-March 2022; Provides Dividend Guidance for the Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥47.95 (vs JP¥15.85 in 2Q 2021)

Upcoming dividend of JP¥45.00 per share

Ube Industries, Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended September 2021 and Fiscal Year Ending March 31, 2022